recommend larger-scale studies with long-term follow-up to evaluate possible adverse effects
Clemmensen et al
Her insurer is Harvard Pilgrim Health Care, which announced in May that it will stop covering GLP-1s for weight loss next year
Read clinical review Safety Saxenda (Liraglutide 3 mg) Geriatric Monitoring: A Clinical Guide for Patients 65 and Older Complete monitoring guide for Saxenda (liraglutide 3 mg) in adults 65 and older, covering renal function, falls risk, cardiac monitoring, drug interactions, and deprescribing criteria with evidence-based protocols
That places it squarely in the compounded category, where the FDA states that compounded drugs are not FDA-approved and that the agency does not verify their safety, effectiveness or quality before they are marketed
Studies have established the roles of these melanocortins in various complex biological pathways